## Abstract Tumor induction and immunity to tumors were studied following the injection of Moloney sarcoma virus (MSV) into mice whose B‐lymphocyte functions had been suppressed by the chronic administration of anti‐IgM antibodies. Two preparations of MSV were used; one which gives rise to tumors w
Suppression of in vitro lymphocyte stimulation in mice bearing primary moloney sarcoma virus-induced tumors
✍ Scribed by H. Kirchner; R.B. Herberman; M. Glaser; D.H. Lavrin
- Book ID
- 115810598
- Publisher
- Elsevier Science
- Year
- 1974
- Tongue
- English
- Weight
- 611 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0008-8749
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Pre‐treatment of BALB/c mice with an intraperitoneal injection of heat‐inactivated serum obtained from BALB/c mice with progressively growing Moloney‐virus‐induced sarcomas (“progressor” mice) shortens the latent period and increases the growth rate and maximum size of primary sarcomas
## Abstract The kinetics of ‘sarcoma’ cell appearance and inflammatory cell infiltration into primary Moloney sarcoma virus (MSV)‐induced tumors has been studied in normal and partially immunosuppressed anti‐lymphocyte‐globulin (ALG)‐treated A/WySn mice. The ALG treatment facilitated an earlier app
## Abstract Adult CBA mice injected with Moloney Sarcoma Virus (MSV) developed tumors within 5 to 8 days which usually completely regressed within 1 month. Maximal tumor size was variable, occurring between 10 and 15 days. Lymphocytes from these animals were examined for activity against syngeneic
## Abstract Purified viruses, viral antigens, and cell extracts have been tested for their ability to stimulate protein synthesis by MSV‐M^1^ regressor spleen cells from BALB/c mice. Immune, but not normal cells, responded to MSV‐M, but not to MSV‐G virus^1^, and to the type‐specific viral envelope